Search research articles
Contact Us
Filters
Showing results (161-170 of 485) with videos related to
Page
of 49
Sort By:
Expert Review of Vaccines
|
October 31, 2013
Economic evaluations of hepatitis A vaccination in middle-income countries
Auliya A Suwantika, Selen Yegenoglu, Arthorn Riewpaiboon, et al.
Vaccines
|
September 9, 2020
Understanding the Improvement in Full Childhood Vaccination Coverage in Ethiopia Using Oaxaca-Blinder Decomposition Analysis
Abrham Wondimu, Qi Cao, Derek Asuman, et al.
BMJ (Clinical Research Ed.)
|
August 20, 2005
Need for differential discounting of costs and health effects in cost effectiveness analyses
Werner B F Brouwer, Louis W Niessen, Maarten J Postma, et al.
Plos One
|
May 30, 2015
Cost-effectiveness of extended-release methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder sub-optimally treated with immediate release methylphenidate
Jurjen van der Schans, Nikos Kotsopoulos, Pieter J Hoekstra, et al.
BMJ (Clinical Research Ed.)
|
July 14, 2012
Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis
Anna K Lugnér, Michiel van Boven, Robin de Vries, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 6, 2022
The Effect of the Drug Life Cycle Price on Cost-Effectiveness: Case Studies Using Real-World Pricing Data
Marcel H Schöttler, Friso B Coerts, Maarten J Postma, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 14, 2011
Practical implications of differential discounting of costs and health effects in cost-effectiveness analysis
Tjalke A Westra, Mehraj B Y Parouty, Jan C Wilschut, et al.
Clinical Therapeutics
|
August 24, 2010
Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands
Tjalke A Westra, Robin de Vries, Johannes J Tamminga, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
May 19, 2021
Economic evaluation of rotavirus vaccination: an important step of the introduction to the national immunization program in Thailand
Onwipa Rochanathimoke, Arthorn Riewpaiboon, Naiyana Praditsitthikorn, et al.
Plos One
|
June 7, 2013
Meningococcal serogroup A, C, W₁₃₅ and Y conjugated vaccine: a cost-effectiveness analysis in the Netherlands
Hiltsje Hepkema, Koen B Pouwels, Arie van der Ende, et al.
Page
of 49
Search research articles
Search
Showing results (161-170 of 485) with videos related to
Sort By:
Page
of 49
Expert Review of Vaccines
|
October 31, 2013
Economic evaluations of hepatitis A vaccination in middle-income countries
Auliya A Suwantika, Selen Yegenoglu, Arthorn Riewpaiboon, et al.
Vaccines
|
September 9, 2020
Understanding the Improvement in Full Childhood Vaccination Coverage in Ethiopia Using Oaxaca-Blinder Decomposition Analysis
Abrham Wondimu, Qi Cao, Derek Asuman, et al.
BMJ (Clinical Research Ed.)
|
August 20, 2005
Need for differential discounting of costs and health effects in cost effectiveness analyses
Werner B F Brouwer, Louis W Niessen, Maarten J Postma, et al.
Plos One
|
May 30, 2015
Cost-effectiveness of extended-release methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder sub-optimally treated with immediate release methylphenidate
Jurjen van der Schans, Nikos Kotsopoulos, Pieter J Hoekstra, et al.
BMJ (Clinical Research Ed.)
|
July 14, 2012
Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis
Anna K Lugnér, Michiel van Boven, Robin de Vries, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 6, 2022
The Effect of the Drug Life Cycle Price on Cost-Effectiveness: Case Studies Using Real-World Pricing Data
Marcel H Schöttler, Friso B Coerts, Maarten J Postma, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 14, 2011
Practical implications of differential discounting of costs and health effects in cost-effectiveness analysis
Tjalke A Westra, Mehraj B Y Parouty, Jan C Wilschut, et al.
Clinical Therapeutics
|
August 24, 2010
Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands
Tjalke A Westra, Robin de Vries, Johannes J Tamminga, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
May 19, 2021
Economic evaluation of rotavirus vaccination: an important step of the introduction to the national immunization program in Thailand
Onwipa Rochanathimoke, Arthorn Riewpaiboon, Naiyana Praditsitthikorn, et al.
Plos One
|
June 7, 2013
Meningococcal serogroup A, C, W₁₃₅ and Y conjugated vaccine: a cost-effectiveness analysis in the Netherlands
Hiltsje Hepkema, Koen B Pouwels, Arie van der Ende, et al.
Page
of 49